Bellevue Life Sciences Ac...

AI Score

0

Unlock

11.40
0.06 (0.53%)
At close: Jan 03, 2025, 9:00 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a
Operating Income -1.83M -35.39K -3.31K -23.81K
Interest Income n/a n/a n/a n/a
Pretax Income 944.59K -35.39K -3.31K -23.81K
Net Income 403.78K -35.39K -3.31K -23.81K
Selling & General & Admin 1.83M 35.39K 3.31K 23.81K
Research & Development n/a n/a n/a n/a
Other Expenses n/a n/a n/a n/a
Operating Expenses 1.83M 35.39K 3.31K 23.81K
Interest Expense n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 1.83M 35.39K 3.31K 23.81K
Income Tax 540.81K -228.48K -236.56K -206.30K
Shares Outstanding (Basic) 5.62M 9.05M 7.93M 7.89M
Shares Outstanding (Diluted) 5.62M 9.05M 7.93M 7.89M
EPS (Basic) 0.07 -0.00 -0.00 -0.00
EPS (Diluted) 0.07 -0.00 -0.00 -0.00
EBITDA 944.59K -35.39K -3.31K -23.81K
Depreciation & Amortization 2.78M 228.49K 236.56K 206.30K